Ep34: Investing in Digital Health: Justin Norden Shares Insights Into Succeeding in DTx

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.

Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.

In this episode, we cover:

• The Healthcare Thesis at GSR Ventures

• Virtual Reality (VR) Digital Therapeutics

• Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx

• What it would take to scale existing Prescription Digital Therapeutics

• The Role Of Health Coaching alongside AI automation

• The Drivers of Success Going Forward for the Digital Therapeutics Market

Guest Links and Resources:

• Connect with Justin Norden on LinkedIn | Twitter

• Visit https://gsrventuresglobal.com

Host Links:

• Connect with Eugene Borukhovich: Twitter | LinkedIn

• Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn

• Connect with YourCoach.health: Website | Twitter

• Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App

• HealthXL: Website | Twitter | Join an Event

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram